Zelira Therapeutics Ltd has released a press release.
September 2020 Quarterly Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Story so far
Earlier from Zelira Therapeutics
- HOPE launches in Australia after TGA approves release
- Thorney Becomes a Substantial Strategic Investor in Zelira
- Zenivol launches in Australia after TGA approves release
- Zelira Forms Subsidiary to Launch Oral Care Products in USA
- Appendix 4E & Financial Statements
Later from Zelira Therapeutics
- Emyria Deal and Autism Observational Trial for HOPE Products
- ZLD Partners with SprinJene to Launch CBD Toothpaste in US
- R&D Tax Incentive Refund
- Zelira Expands HOPE Distribution to Washington DC, USA
- December 2020 Quarterly Report
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics